Dr. Christopher Bichakjian is fellowship-trained Mohs surgeon, who provides patient care within the University of Michigan Rogel Cancer Center. He offers expert treatment for melanoma and non-melanoma skin cancers. Dr. Bichakjian received his medical degree from Radboud University in The Netherlands and completed his dermatology residency and fellowship in dermatologic (Mohs) surgery and cutaneous oncology at the University of Michigan. He joined the cutaneous surgery and oncology faculty of the U-M Department of Dermatology in 2004.
Dr. Bichakjian has a special interest in Merkel cell carcinoma and established one of the first multidisciplinary programs in the world for this rare skin cancer. Through his involvement with the American Joint Committee on Cancer (AJCC), the National Comprehensive Cancer Network (NCCN), and the American Academy of Dermatology (AAD), Dr. Bichakjian is helping to improve and develop optimal staging and clinical practice guidelines in cutaneous oncology.
Dr. Bichakjian is a Professor of Dermatology, Chief of the Division of Cutaneous Surgery and Oncology, and Director of the Multidisciplinary Melanoma and Merkel Cell Carcinoma Programs at Michigan Medicine. In addition, he directs the U-M Micrographic Surgery and Dermatologic Oncology Fellowship Training Program.
Dr. Bichakjian leads our skin cancer programs, including Mohs surgery unit and the Multi-disciplinary Melanoma clinic.